For people living with spinal muscular atrophy (SMA), access to suitable and effective treatment often depends on which EU country they live in. Stakeholders are now calling for equal access to standards of care across the bloc.
Ensuring sufficient plasma collection in Europe remains a thorny issue but the forthcoming revision of the EU framework for pharmaceuticals offers the potential to turn the tide.
The winner of the DesignEuropa awards has come from the healthcare sector for the second edition in a row, highlighting the increasing importance of a user-friendly approach in developing medical devices. The portable and compact patient monitor IntelliVueX3, developed by...
The COVID-19 pandemic has exposed the lack of medical stockpiles across the EU and the vulnerability of EU supply chains for critical medical countermeasures, reinforcing the message that political leadership remains at the core of creating resilient healthcare to fight future health crises.
Health experts and policymakers have called on governments to step up and take the pandemic as a wake-up call to adopt impactful mental health policies, as outlined in a new report.
Digital education, encouraging collaboration and financial support to connect rural areas are among the actions still needed for rural areas to benefit from digital health opportunities.
The COVID crisis has scrambled the EU’s priorities when it comes to health. But while all eyes have been on COVID-19, European institutions have been carrying on their “silent battle” against an older enemy: cancer.
‘Mix and match’ or heterologous vaccination strategy split the scientists over the usage of different vaccines against covid. While some argue that this would boost the protection others say that more evidence is needed.
The European Commission has signed a joint procurement framework contract with the pharmaceutical company Eli Lilly for the supply of monoclonal antibody treatment for coronavirus patients.
Welcome to EURACTIV’s very first Health Brief! In this first edition, we spoke to the European Commission's director-general for health and food safety, Sandra Gallina, to find out what is in store this autumn when it comes to health.
The European Parliament has given its green light to a controversial new antimicrobials regulation, dismissing a motion calling for tighter restrictions on antibiotics use in animals and allowing the Commission to move forward on its plans to tackle anti-microbial resistance.
For now, vaccines are capable of dealing with SARS-CoV-2 virus variants circulating in the world. But as new variants potentially emerge vaccines might need to be adapted to fight the new strains.
European Commission President Ursula von der Leyen has announced a €50 billion investment to strengthen the European health union in her annual State of the Union speech in efforts to concrete the EU as a world leader on health.
A new delegated act proposed by the European Commission to tackle anti-microbial resistance (AMR) has drawn harsh criticisms from the Green group in the European Parliament, who are calling for the use of antibiotics in animals to be restricted.
As children across the European Union are going back to school, ECDC is encouraging countries to “appropriately” balance children's physical and mental health needs while ensuring COVID-19 prevention.
More than 256 million adults in the EU are now fully vaccinated against COVID-19 as the rate among the adult population reached 70% on Tuesday (31 August), which the European Commission president Ursula von der Leyen called “a great achievement".
One-half of COVID-19 patients discharged from a hospital in Wuhan, China, still experience at least one persistent symptom after 12 months, a study in the Lancet medical journal has shown. Its authors say that this needs to be considered when planning post-pandemic healthcare services.
It has been around eight months since the first COVID vaccine was authorised in the European Union. As vaccination uptake among adults is nearing 70%, a new debate on whether a COVID-19 booster jab might be necessary is taking place across member states.
Europe is letting thousands of COVID-19 vaccine doses expire while only 1% of people in low-income countries and 28% of the world population has received at least a dose of a COVID-19 vaccine.
The world is on a mission to eliminate viral hepatitis as a major public health threat by 2030. But the World Health Organisation has warned that despite positive progress in recent years, “there is still a long way to go”.
